Total Payments
$9,902
2024 Payments
$1,549
Companies
38
Transactions
571
Medicare Patients
5,623
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$9,813 (99.1%)
Education$89.27 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,813 | 559 | 99.1% |
| Education | $89.27 | 12 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,519 | 98 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,164 | 65 | $0 (2024) |
| PFIZER INC. | $951.16 | 58 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $685.10 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $683.85 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $540.35 | 33 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $487.87 | 28 | $0 (2022) |
| Allergan, Inc. | $481.00 | 33 | $0 (2020) |
| Amgen Inc. | $449.25 | 24 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $424.75 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,549 | 80 | ABBVIE INC. ($355.97) |
| 2023 | $1,486 | 78 | ABBVIE INC. ($268.84) |
| 2022 | $1,402 | 84 | ABBVIE INC. ($358.54) |
| 2021 | $1,405 | 90 | AbbVie Inc. ($451.73) |
| 2020 | $1,084 | 69 | GlaxoSmithKline, LLC. ($264.33) |
| 2019 | $895.80 | 53 | Boehringer Ingelheim Pharmaceuticals, Inc. ($153.97) |
| 2018 | $1,043 | 56 | GlaxoSmithKline, LLC. ($229.99) |
| 2017 | $1,038 | 61 | Janssen Pharmaceuticals, Inc ($244.67) |
All Payment Transactions
571 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: UROLOGY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: PAIN | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Biological | ||||||
| 10/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Obesity | ||||||
| 09/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Durable Pump | ||||||
| 09/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/09/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,720 | 3,092 | $930,740 | $283,697 |
| 2022 | 13 | 1,535 | 2,746 | $807,209 | $263,498 |
| 2021 | 10 | 1,103 | 2,826 | $800,166 | $281,446 |
| 2020 | 19 | 1,265 | 2,926 | $726,691 | $247,105 |
Total Patients
5,623
Total Services
11,590
Medicare Billing
$1.1M
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 389 | 1,635 | $551,100 | $164,330 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 286 | 286 | $114,400 | $40,563 | 35.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 264 | 267 | $93,450 | $22,901 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 143 | 204 | $46,875 | $12,942 | 27.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 39 | $27,300 | $9,254 | 33.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 106 | 106 | $14,310 | $8,036 | 56.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 55 | 78 | $23,400 | $7,200 | 30.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 27 | $14,310 | $4,718 | 33.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 111 | 111 | $8,658 | $3,756 | 43.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $3,700 | $2,891 | 78.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $7,350 | $2,705 | 36.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 225 | 246 | $17,712 | $2,597 | 14.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $5,675 | $1,009 | 17.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 22 | 36 | $1,800 | $575.29 | 32.0% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 14 | 14 | $700.00 | $218.40 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 340 | 1,420 | $468,600 | $148,927 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 242 | 242 | $90,320 | $35,281 | 39.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 209 | 211 | $73,850 | $18,816 | 25.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 85 | 173 | $46,440 | $17,713 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $34,225 | $10,040 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 119 | $26,775 | $8,491 | 31.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 115 | 115 | $15,525 | $8,079 | 52.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 25 | 27 | $18,900 | $6,725 | 35.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 122 | 122 | $9,516 | $4,109 | 43.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $6,090 | $2,244 | 36.8% |
About Dr. Abdulfatah Elshaar, M.D
Dr. Abdulfatah Elshaar, M.D is a Internal Medicine healthcare provider based in Norwood, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821045550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdulfatah Elshaar, M.D has received a total of $9,902 in payments from pharmaceutical and medical device companies, with $1,549 received in 2024. These payments were reported across 571 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($9,813).
As a Medicare-enrolled provider, Elshaar has provided services to 5,623 Medicare beneficiaries, totaling 11,590 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Norwood, MA
- Active Since 05/28/2006
- Last Updated 07/18/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1821045550
Products in Payments
- ELIQUIS (Drug) $787.18
- UBRELVY (Drug) $748.53
- TRELEGY ELLIPTA (Drug) $653.80
- LINZESS (Drug) $591.97
- JARDIANCE (Drug) $466.38
- ENTRESTO (Drug) $401.79
- CHANTIX (Drug) $300.52
- FARXIGA (Drug) $285.63
- Vascepa (Drug) $274.88
- XARELTO (Drug) $256.16
- INVOKANA (Drug) $225.69
- NURTEC ODT (Drug) $207.27
- ANORO (Drug) $206.89
- GEMTESA (Drug) $206.60
- MOUNJARO (Drug) $168.76
- BYSTOLIC (Drug) $161.61
- ZENPEP (Drug) $153.60
- QULIPTA (Drug) $150.77
- BREO (Drug) $146.25
- SPIRIVA RESPIMAT (Drug) $143.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Norwood
Matthew Sullivan, Md, MD
Internal Medicine — Payments: $2,237
Internal Medicine $2,237
Dr. Savitha Gowda, M.d, M.D
Internal Medicine — Payments: $1,502
Internal Medicine $1,502
Dr. Jane Fogg, M.d, M.D
Internal Medicine — Payments: $1,066
Internal Medicine $1,066
Dr. Michele Coviello, Md, MD
Internal Medicine — Payments: $1,066
Internal Medicine $1,066
Neil Birnbaum, Md, MD
Internal Medicine — Payments: $958.68
Internal Medicine $958.68
Joseph Perrotto, Md, MD
Internal Medicine — Payments: $407.19
Internal Medicine $407.19